| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.05. | BiomX subsidiary launches mobile command app for operators | 4 | Investing.com | ||
| 06.05. | BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand | 1 | GlobeNewswire (USA) | ||
| 05.05. | BiomX Inc. - 8-K, Current Report | - | SEC Filings | ||
| BIOMX Aktie jetzt für 0€ handeln | |||||
| 30.04. | BiomX Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 16.04. | BiomX: Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems | 3 | GlobeNewswire (USA) | ||
| 13.04. | BiomX Accelerates Defense Technology Buildout with DFSL Acquisition | 294 | GlobeNewswire (Europe) | NETANYA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE: PHGE) ("BiomX" or the "Company") today announced that it has accelerated the exercise of its previously disclosed exclusive option... ► Artikel lesen | |
| 13.04. | BiomX: Acquisition Of Zorronet Expands Into AI-Driven Defense And Security Command Systems | 2 | pulse2.com | ||
| 10.04. | BiomX Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 10.04. | T3 Defense verkauft ZorroNet an BiomX in Aktie-und-Cash-Deal | 7 | Investing.com Deutsch | ||
| 10.04. | BiomX completes acquisition of AI defense software firm Zorronet | 1 | Investing.com | ||
| 10.04. | BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications | 531 | GlobeNewswire (Europe) | NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the "Company") today announced that it has completed the acquisition of 100% of Zorronet from... ► Artikel lesen | |
| 10.04. | BiomX Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | BiomX kündigt Übernahme von DFSL an und schwenkt auf Verteidigungssektor um | 10 | Investing.com Deutsch | ||
| 31.03. | BiomX to acquire laser detection firm DFSL in defense pivot | 1 | Investing.com | ||
| 31.03. | BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System | 313 | GlobeNewswire (Europe) | NETANYA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) today announced that it has entered into an option agreement to acquire control of DFSL, a developer of proprietary... ► Artikel lesen | |
| 30.03. | BiomX Adds Former Mossad Deputy to Advisory Board | 1 | GlobeNewswire (USA) | ||
| 27.03. | BiomX: Delisting-Gefahr an der NYSE American wegen Eigenkapitalmängeln | 1 | Investing.com Deutsch | ||
| 27.03. | BiomX Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.03. | BiomX receives NYSE American non-compliance notice | 2 | Seeking Alpha | ||
| 27.03. | BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency | 186 | GlobeNewswire (Europe) | NETANYA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the "Company") today announced that on March 25, 2026, the Company received a notice from the staff of NYSE American... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 76,40 | -2,98 % | BioNTech-Krise vs. Emyria-Durchbruch? Warum Daten jetzt die Forschung schlagen | ||
| EVOTEC | 4,618 | -1,74 % | KURSRUTSCH bei Nel ASA und Evotec! KURSCHANCE bei HPQ Silicon! | Steht die Aktie von HPQ Silicon vor einer Neubewertung? Dafür gibt es jedenfalls gute Gründe. Die Hochleistungsbatterien haben erneut überzeugt. Damit könnte für Anwendungen in Drohnen, Verteidigung... ► Artikel lesen | |
| MODERNA | 42,000 | -0,52 % | Moderna-Aktie steigt weiter: Hantavirus im Fokus | Die Sorge rund um das Hantavirus wächst: Auf dem Kreuzfahrtschiff "Hondius" wurden mehrere Infektionen mit der seltenen südamerikanischen Andes-Variante registriert, drei Personen starben. Trotz des... ► Artikel lesen | |
| VALNEVA | 2,540 | +0,95 % | Valneva senkt Prognose und baut Stellen ab | Beim Impfstoffspezialisten Valneva SE häufen sich im ersten Quartal 2026 die Belastungen: Der Nettoverlust weitete sich auf 32,1 Millionen Euro nach 9,2 Millionen Euro im Vorjahr aus, das bereinigte... ► Artikel lesen | |
| AMGEN | 282,15 | +0,46 % | Dividendenbekanntmachungen (15.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0514 EUR AF GRUPPEN ASA NO0003078107 6,5 NOK 0,6029 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | 14,990 | +2,11 % | PALATIN TECHNOLOGIES INC - 10-Q, Quarterly Report | ||
| VIVOSIM LABS | 1,300 | +0,78 % | VivoSim Labs, Inc.: VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales | SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,178 | +4,90 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights | Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA)... ► Artikel lesen | |
| SANGAMO THERAPEUTICS | 0,126 | 0,00 % | XFRA GBY: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSANGAMO THERAP.INC.DL-... ► Artikel lesen | |
| INTELLIA THERAPEUTICS | 11,580 | -1,53 % | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates | Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA submission; anticipate U.S. launch in first half of 2027Recently resumed patient screening in MAGNITUDE... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,309 | +3,00 % | Defence Therapeutics Inc.: Defence Therapeutics Announces Grant of Restricted Stock Units | Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision... ► Artikel lesen | |
| PACIFIC BIOSCIENCES OF CALIFORNIA | 0,985 | +1,69 % | PacBio: HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss | ||
| CARDIOL THERAPEUTICS | 1,152 | +1,05 % | Stocks in Play: Cardiol Therapeutics Inc. | ||
| ARBUTUS BIOPHARMA | 3,610 | -1,10 % | Arbutus Biopharma Corporation: Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update | Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna Strong financial position with cash, cash equivalents and marketable securities... ► Artikel lesen | |
| REDHILL BIOPHARMA | 1,020 | -0,97 % | RedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights | 2025 was a year of tenacity, strategic transactions and building traction for RedHill
Talicia® business transformed:
Formation of Talicia Holdings Inc. (THI) and... ► Artikel lesen |